Sapheon Completes First Closing in Series B Preferred Offering; Dr. Aaron Berez Joins Board of DirectorsAugust 24, 2012 1:51 am | by The Associated Press | News | Comments
SANTA ROSA, Calif.--(BUSINESS WIRE)--Aug 24, 2012--Sapheon Inc. has completed the first closing in its $18.5 million Series B Preferred equity offering. The Company issued 4,775,291 shares worth $8.6 million to Series B purchasers and convertible notes holders. The Company intends to use the...
Tiny medical device maker Corindus Vascular Robotics has scored an A-list partner - the company announced that Royal Philips Electronics (NYSE: PHG, AEX: PHI) has agreed to distribute Corindus’ first FDA-approved product, a robotic-assisted system for the minimally invasive treatment of obstructed coronary arteries, which is known as percutaneous coronary intervention (PCI).
Interleukin Genetics Inc. (OTCQB: ILIU) announced Friday that Lewis Bender resigned as CEO effective Thursday, and will be replaced by Kenneth Kornman, the company’s founder, president and chief scientific officer.
Healthcare informatics company eClinicalWorks is busting out of the seams of its existing Westborough location. The company said late Thursday that it paid $7.7 million for a 61,000-square-foot facility at 1 Technology Dr.
After decades working in the medical device field, Scott Epstein, 55, of Boston is preparing to take pAguaMedicina, an FDA-approved pediatric ureteral stent, to market.
A federal appeals court has reversed a lower court decision in a patent dispute over a coronary stent involving Boston Scientific Corp. (NYSE: BSX), ruling that the lower court got it wrong when it ruled in favor of the Natick medical device giant.
A pair of former ArthroCare senior executives are in the hot seat for their alleged roles in a securities fraud scheme that cost shareholders $400 million. Former ArthroCare (NSDQ:ARTC) senior executives John Raffle and David Applegate were arrested yesterday morning for alleged roles in a securities fraud scheme that cost shareholders more than $400 million. Legal News, News Well, Wall Street Beatread more
GI Dynamics CEO Stuart Randle tells MassDevice.com that the FDA's decision to let the company jump to a pivotal trial for its EndoBarrier weight loss device could speed up the medical device company's commercial launch in the U.S. A clearly elated Stu Randle told MassDevice.com today that the FDA's decision to allow GI Dynamics (ASX:GID) to skip directly to a pivotal trial for its EndoBarrier gastrointestinal liner represented a "huge milestone" for the medical device company. News Well, Bariatrics, FDAread more
CareFusion recalls more Alaris infusion pumps, the 3rd recall in as many months, prompting a 2% slide on Wall Street. CareFusion (NYSE:CFN) lost some points on Wall Street after the FDA slapped its latest infusion pump recall with Class I status, reserved for the most potentially dangerous device defects. CareFusion announced the 3rd recall in as many months, the 2nd affecting infusion pumps, after discovering issues with the keypad overlay on Alaris model 8100 infusion pump module door. News Well, Recallsread more
SHENZHEN, China, Aug. 23, 2012 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ("Nepstar" or the "Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter ended June 30, 2012. Financial Highlights Revenue increased by 1.8% to RMB617.6 millio...
TITLE: "Nothing's Free" LENGTH: 30 Seconds AIRING: The Mitt Romney campaign would not disclose where the ad is airing. KEY IMAGES: "Some think Obamacare is the same as free health care, but nothing is free," a male narrator says as a graphic of two pills forming an "equals" sign between the...
On August 20, 2012, InSightec announced it received approval from the Food and Drug Administration (FDA) to begin Phase I clinical trials evaluating the use of its ExAblate Neuro system for the treatment of patients with tremor-dominant Parkinson’s Disease (PD). This device is the first clinical system to use magnetic resonance guided focused ultrasound (MRgFUS) through an intact skull, offering non-invasive transcranial treatment without any incisions or ionizing radiation.
Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today that it has launched its newest Minimally Invasive Surgery (MIS) device, which is called the BridgePoint Spinous Process Fixation System.
Former Director of eLEAF, Noël Coopmans, joins rapid growing innovator in the treatment of vascular diseases Blue Medical, the global medical device company and innovator in the treatment of vascular diseases, today announces the appointment of Noël Coopmans as Blue Medical's CEO. Noël...
NuVasive vows to "vigorously" defend against Medtronic's latest claims in a long-running patent-infringement row over spinal devices. NuVasive Inc. (NSDQ:NUVA) is prepared to go another round in the long-running spinal patent battle against Medtronic (NYSE:MDT). Legal News, News Well, Patent Infringement, Spinalread more